相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intranasal curcumin and sodium butyrate modulates airway inflammation and fibrosis via HDAC inhibition in allergic asthma
Ramiya Islam et al.
CYTOKINE (2022)
Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
Xingrui He et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Maria Serena Roca et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Beyond regulations at DNA levels: A review of epigenetic therapeutics targeting cancer stem cells
Shunhao Zhang et al.
CELL PROLIFERATION (2021)
Phenethyl isothiocyanate reduces breast cancer stem cell-like properties by epigenetic reactivation of CDH1
Taolan Zhang et al.
ONCOLOGY REPORTS (2021)
The bone microenvironment invigorates metastatic seeds for further dissemination
Weijie Zhang et al.
CELL (2021)
Epigenetic Signaling of Cancer Stem Cells During Inflammation
Zaoqu Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA Methylation
Weini Wang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway
Yun Liu et al.
CELL DEATH & DISEASE (2021)
Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells
Zhigeng Zou et al.
BRITISH JOURNAL OF CANCER (2021)
Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63
Yingjie Liu et al.
NATURE COMMUNICATIONS (2021)
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
Chunhong Hu et al.
CLINICAL EPIGENETICS (2021)
MicroRNA Therapeutics in Cancer: Current Advances and Challenges
Soha Reda El Sayed et al.
CANCERS (2021)
The key roles of cancer stem cell-derived extracellular vesicles
Chaoyue Su et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
He-Ming Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically
Liyan Wang et al.
MOLECULAR THERAPY (2020)
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Stem cells in cancer initiation and progression
Jeevisha Bajaj et al.
JOURNAL OF CELL BIOLOGY (2020)
miR-27a ameliorates chemoresistance of breast cancer cells by disruption of reactive oxygen species homeostasis and impairment of autophagy
Shinobu Ueda et al.
LABORATORY INVESTIGATION (2020)
Low-frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia
Bowen Yan et al.
LEUKEMIA (2020)
Crosstalk between autophagy and metabolic regulation of cancer stem cells
Mouradi El Hout et al.
MOLECULAR CANCER (2020)
HBO1 is required for the maintenance of leukaemia stem cells
Laura MacPherson et al.
NATURE (2020)
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis
Hao Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes
Elisabet Cuyas et al.
AGING-US (2020)
Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy
Chen Wang et al.
STEM CELL RESEARCH & THERAPY (2020)
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
David S. Hong et al.
BRITISH JOURNAL OF CANCER (2020)
The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma
Parvez Vora et al.
CELL STEM CELL (2020)
Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1
Valentina Lulli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells
Ji Eun Jang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid
Mariah M. Hoffman et al.
CANCERS (2020)
Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation
Vijesh Kumar Yadav et al.
CANCERS (2020)
Histone Deacetylases Inhibit the Snail2-Mediated EMT During Metastasis of Hepatocellular Carcinoma Cells
Yue Hu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
EZH2: a novel target for cancer treatment
Ran Duan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Hypoxia-mediated cancer stem cell resistance and targeted therapy
Xiaoyu Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents
Carsten Riether et al.
NATURE MEDICINE (2020)
TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer
Bit Na Kim et al.
Scientific Reports (2020)
SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells
Weiwei Tao et al.
EMBO MOLECULAR MEDICINE (2020)
The dormant cancer cell life cycle
Tri Giang Phan et al.
NATURE REVIEWS CANCER (2020)
Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells
Puneet Agarwal et al.
CELL STEM CELL (2019)
Emerging roles of and therapeutic strategies targeting BRD4 in cancer
Mary E. White et al.
CELLULAR IMMUNOLOGY (2019)
Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells
Mingqing Wu et al.
ONCOGENE (2019)
Tumor Cell Dormancy-Triggered by the Niche
Daniela Senft et al.
DEVELOPMENTAL CELL (2019)
Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
Wei Lu et al.
DEVELOPMENTAL CELL (2019)
DNA methylation and chromatin modifiers in colorectal cancer
Veronika Vymetalkova et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Molecular Mechanisms Directing PRC2 Recruitment and H3K27 Methylation
Anne Laugesen et al.
MOLECULAR CELL (2019)
AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition
Kai-li Zhang et al.
ACTA PHARMACOLOGICA SINICA (2019)
SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence
Sen Ye et al.
CANCER RESEARCH (2019)
Long non-coding RNA FENDRR attenuates the sternness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR
Fangchao Gong et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail
Xinyao Lin et al.
NATURE COMMUNICATIONS (2019)
A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells
Abir Arfaoui et al.
EMBO MOLECULAR MEDICINE (2019)
Guadecitabine (SGI-110): an investigational drug for the treatment of myelodysplastic syndrome and acute myeloid leukemia
Georgina S. Daher-Reyes et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Functional roles of circular RNAs during epithelial-to-mesenchymal transition
Bing-Qing Shang et al.
MOLECULAR CANCER (2019)
The Role of Non-coding RNAs in Oncology
Frank J. Slack et al.
CELL (2019)
MicroRNAs' control of cancer cell dormancy
Tatiana G. Ruksha
CELL DIVISION (2019)
MIR93 (microRNA-93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy
Tianzhi Huang et al.
AUTOPHAGY (2019)
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness
Frank H. C. Cheng et al.
CANCER SCIENCE (2019)
Up-regulation of SPINT2/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion
Fernanda Marconi Roversi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Chromatin accessibility and the regulatory epigenome
Sandy L. Klemm et al.
NATURE REVIEWS GENETICS (2019)
Extensive subclonal mutational diversity in human colorectal cancer and its significance
Lawrence A. Loeb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia
S. Fujita et al.
LEUKEMIA (2018)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
Frank Lyko
NATURE REVIEWS GENETICS (2018)
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
Tamara Maes et al.
CANCER CELL (2018)
Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma
Jing Meng et al.
CANCER RESEARCH (2018)
MiR-146a promotes the asymmetric division and inhibits the self-renewal ability of breast cancer stem-like cells via indirect upregulation of Let-7
Rui Liang et al.
CELL CYCLE (2018)
Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
Hongping Zheng et al.
HEPATOLOGY (2018)
Tumor stressors induce two mechanisms of intracellular P-glycoprotein-mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones
Lina Al-Akra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
The biology and role of CD44 in cancer progression: therapeutic implications
Chen Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway
Tianxiao Gong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia
Bin Zhang et al.
NATURE MEDICINE (2018)
Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine
Mao-Hua Cai et al.
SCIENTIFIC REPORTS (2018)
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma
Xue-Kang Qi et al.
THERANOSTICS (2018)
Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1
Ya-Ling Hsu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Aspirin cooperates with p300 to activate the acetylation of H3K9 and promote FasL-mediated apoptosis of cancer stem-like cells in colorectal cancer
Zhigang Chen et al.
THERANOSTICS (2018)
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy
Marcella La Noce et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Nucleotide Modifications Decrease Innate Immune Response Induced by Synthetic Analogs of snRNAs and snoRNAs
Grigory Stepanov et al.
GENES (2018)
AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells
Ji Eun Jang et al.
CLINICAL CANCER RESEARCH (2017)
HULC: an oncogenic long non-coding RNA in human cancer
Xin Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Targeting breast cancer stem cells by novel HDAC3-selective inhibitors
Hao-Yu Hsieh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells
Ningning Yan et al.
EXPERIMENTAL CELL RESEARCH (2017)
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Marta Prieto-Vila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk et al.
LANCET ONCOLOGY (2017)
Epigenetics in cancer stem cells
Tan Boon Toh et al.
MOLECULAR CANCER (2017)
Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy
Guifa Xi et al.
MOLECULAR CANCER (2017)
Intra-tumor heterogeneity from a cancer stem cell perspective
Pramudita R. Prasetyanti et al.
MOLECULAR CANCER (2017)
Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway
Lanfang Zhang et al.
MOLECULAR CARCINOGENESIS (2017)
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Wei Qi et al.
NATURE CHEMICAL BIOLOGY (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?
Zhongji Meng et al.
FRONTIERS IN IMMUNOLOGY (2017)
Targeting Lung Cancer Stem Cells: Research and Clinical Impacts
Norashikin Zakaria et al.
FRONTIERS IN ONCOLOGY (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Brian B. Liau et al.
CELL STEM CELL (2017)
The Ezh2 polycomb group protein drives an aggressive phenotype in melanoma cancer stem cells and is a target of diet derived sulforaphane
Matthew L. Fisher et al.
MOLECULAR CARCINOGENESIS (2016)
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction
Ende Zhao et al.
NATURE IMMUNOLOGY (2016)
CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells
Y. Zhao et al.
ONCOGENE (2016)
BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
Yuhki Yokoyama et al.
CANCER RESEARCH (2016)
A miR-34a-Numb Feedforward Loop Triggered by Inflammation Regulates Asymmetric Stem Cell Division in Intestine and Colon Cancer
Pengcheng Bu et al.
CELL STEM CELL (2016)
CD44: More than a mere stem cell marker
I. Morath et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone
Sambad Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Combined Effects of Suberoylanilide Hydroxamic Acid and Cisplatin on Radiation Sensitivity and Cancer Cell Invasion in Non-Small Cell Lung Cancer
Jianguo Feng et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Mechanistic diversity in ATP-binding cassette (ABC) transporters
Kaspar P. Locher
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Arginine dependence of tumor cells: targeting a chink in cancer's armor
M. D. Patil et al.
ONCOGENE (2016)
Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway
Z-M Zhang et al.
ONCOGENE (2016)
Downregulation of DNA-PKcs suppresses P-gp expression via inhibition of the Akt/NF-κB pathway in CD133-positive osteosarcoma MG-63 cells
Ka Li et al.
ONCOLOGY REPORTS (2016)
Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets
Ryo Sato et al.
STEM CELLS (2016)
Rapidly cycling Lgr5+ stem cells are exquisitely sensitive to extrinsic dietary factors that modulate colon cancer risk
Eunjoo Kim et al.
CELL DEATH & DISEASE (2016)
Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
Yu-Lun Chen et al.
CELLULAR ONCOLOGY (2016)
Mechanistic diversity in ATP-binding cassette (ABC) transporters
Kaspar P. Locher
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
Marta Di Martile et al.
ONCOTARGET (2016)
Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
Bisrat G. Debeb et al.
ONCOTARGET (2016)
miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells
Mrinmay Chakrabarti et al.
PLOS ONE (2016)
Suberoylanilide hydroxamic acid represses glioma stem-like cells
Che-Chia Hsu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
Mark I. James et al.
CANCER LETTERS (2015)
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells
Michele Cioffi et al.
GUT (2015)
Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer
Jens U. Marquardt et al.
JOURNAL OF HEPATOLOGY (2015)
Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer
David R. Li et al.
JOURNAL OF UROLOGY (2015)
Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
Xin Ye et al.
NATURE (2015)
Acetylation site specificities of lysine deacetylase inhibitors in human cells
Christian Scholz et al.
NATURE BIOTECHNOLOGY (2015)
A Big Bang model of human colorectal tumor growth
Andrea Sottoriva et al.
NATURE GENETICS (2015)
NR2F1 controls tumour cell dormancy via SOX9-and RAR beta-driven quiescence programmes
Maria Soledad Sosa et al.
NATURE COMMUNICATIONS (2015)
Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy
Haiyan Zhai et al.
ONCOTARGET (2015)
The role of histone acetyltransferases in normal and malignant hematopoiesis
Xiao-Jian Sun et al.
FRONTIERS IN ONCOLOGY (2015)
Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics
Maria Koutsaki et al.
CANCER LETTERS (2014)
Epigenetic Targeting of Ovarian Cancer Stem Cells
Yinu Wang et al.
CANCER RESEARCH (2014)
Epigenetic Reprogramming Modulates Malignant Properties of Human Liver Cancer
Chiara Raggi et al.
HEPATOLOGY (2014)
Astemizole Arrests the Proliferation of Cancer Cells by Disrupting the EZH2-EED Interaction of Polycomb Repressive Complex 2
Xiangqian Kong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A microRNA-operated switch of asymmetric-to-symmetric cancer stem cell divisions
Robin G. Lerner et al.
NATURE CELL BIOLOGY (2014)
MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells
Wei-Lun Hwang et al.
NATURE CELL BIOLOGY (2014)
HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein
Jianfang Chen et al.
PLOS ONE (2014)
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells
Makiko Ono et al.
SCIENCE SIGNALING (2014)
Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1
Dong Soon Choi et al.
STEM CELLS (2014)
Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
Ming-Tsang Chiao et al.
AUTOPHAGY (2013)
Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck
Kazuaki Chikamatsu et al.
CANCER SCIENCE (2013)
MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells
Wei-Wei Shen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/-catenin pathway
Chiara Riganti et al.
NEURO-ONCOLOGY (2013)
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
N. Syed et al.
CELL DEATH & DISEASE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion
Eric R. Lechman et al.
CELL STEM CELL (2012)
MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
Weiwei Cheng et al.
FEBS JOURNAL (2012)
Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2′-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis
Jing Tian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
Tino Schenk et al.
NATURE MEDICINE (2012)
An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state
Christos Polytarchou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Autophagy positively regulates the CD44+CD24-/low breast cancer stem-like phenotype
Silvia Cufi et al.
CELL CYCLE (2011)
Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
Dara Nalls et al.
PLOS ONE (2011)
Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by Methyl-CpG binding proteins and histone modifications
Imke Mueller et al.
BMC CANCER (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
Anne M. Friel et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2010)
Many colorectal cancers are flat clonal expansions
Kimberly D. Siegmund et al.
CELL CYCLE (2009)
Cellular Quiescence in Mammary Stem Cells and Breast Tumor Stem Cells: Got Testable Hypotheses?
David C. Harmes et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers
Kimberly D. Siegmund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cancer stem cell epigenetics and chemoresistance
Francesco Crea et al.
EPIGENOMICS (2009)
Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells
Kenneth K. W. To et al.
MOLECULAR CANCER RESEARCH (2008)
分享论文
